CEO received an award of 10K LH derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Feb 10, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Feb 12, 2026
CEOGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000920148-26-000070
- Filed / recorded
Added to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly IssuerLABCORP HOLDINGS INC. Reporting personAdam H Schechter RelationshipDirector, Officer Officer titlePresident & CEO SecurityRestricted Stock Unit TableDerivative (Table II) Transaction dateFeb 10, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
- The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027.
- This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Around the same time
April McClain Delaney boughtDemocrat, Representative, MD district 6D · MD-62 different filers disclosed LH within 90 days. Disclosed 27 days after the transaction; reported as an official range, not an exact amount.
April McClain Delaney boughtDemocrat, Representative, MD district 6D · MD-6 2 different filers disclosed LH within 90 days. Disclosed 34 days after the transaction; reported as an official range, not an exact amount.
The boss of Labcorp sold $2.44M of Labcorp shares. Nobody planned it ahead of time.
